To access Physician Decision Support please click on the following:

It appears that our website is not compatible with your browser. Please use one of the following browsers to have the best website experience: Chrome 52+, Firefox 47+, Edge 25+, Safari 9.1.2+, IE11

If IE11 does not work please check your "Compatibility Settings" and follow the instructions below:

1. Open up Internet Explorer (IE 11)

2. Press the Alt key on your keyboard, this will make a menu bar appear.

3. Click on the Tools menu tab.

4. Select the Compatibility View settings option.

5. Uncheck the "Display intranet sites in Compatibility View" option

6. Make sure to remove site from the Websites you've added to Compatibility View list

Insights / October 16, 2019 / by beaconlbs

Featured Lab-Of-Choice: BioReference Laboratories, Inc.

BeaconLBS has invited the Labs-of-Choice™ to provide some more information about themselves for a blog series featuring each of the Labs-of-Choice. The following content was provided by the featured lab, BioReference Laboratories, Inc.

Company Description: Clinical Reference Lab (General Testing)

BioReference Laboratories, Inc., a wholly owned subsidiary of OPKO Health, Inc., is the third largest clinical laboratory in the United States, utilized by healthcare providers in the detection and diagnosis of diseases. The BioReference family of laboratories includes GenPath Diagnostics, specializing in Oncology, Urology and Women’s Health, and GeneDx, a world renowned genetics laboratory specializing in rare and inherited disorders. As the healthcare landscape continues to shift, full service laboratories—those that can provide not only the breadth of testing necessary, but also a positive customer experience—are more important than ever. As a full service laboratory, BioReference houses a large amount of data which can be leveraged to implement value-based care platforms and save patients and providers downstream costs, while delivering high quality patient care.


You Might Also Like:
Frequency Limits in Drug Testing

Toxicology / December 05, 2018 / by beaconlbs

Frequency Limits in Drug Testing

Why do payers put limitations on the frequency of urine drug screening? Learn about the history, guidelines, and payer response in our blog.

Making Sense of Prostate-Specific Antigen (PSA) Testing

Global Lab Testing / January 14, 2019 / by beaconlbs

Making Sense of Prostate-Specific Antigen (PSA) Testing

Confusion exists the role of routine PSA testing in screening for prostate cancer. BeaconLBS answers your questions below in our blog about the history, role and evidence regarding routine PSA testing.